Biocon  >>  Phase 3
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02468101214161820
            
            
             
Alzumab (itolizumab) / Biocon, Equillium, Ono Pharma           
          
            
             
Semglee (insulin glargine-yfgn) / PiSA Farmaceutica, Biocon, Viatris           
          
            
             
Nesbell (darbepoetin alfa biosimilar) / Fuji Pharma, Chong Kun Dang, Alvogen, Biocon           
          
            
             
insulin tregopil (IN-105) / Biocon           
          
            
             
Bmab 1000 (denosumab biosimilar) / Biocon, Yoshindo           
          
            
             
Ogivri (trastuzumab-dkst) / Biocon, Sandoz           
          
            
             
Bmab1200 (ustekinumab biosimilar) / Biocon, Yoshindo           
          
            
             
Fulphila (pegfilgrastim-jmdb) / Biocon           
          
            
             
Krabeva (bevacizumab biosimilar) / Biocon, Sandoz           
          
            
             
MYL-1401A (adalimumab biosimilar) / Biocon, AbbVie           
          
            
             
Yesafili (aflibercept biosimilar) / J&J, Biocon           
          
            
             
adintrevimab (ADG20) / Invivyd, Biocon           
          
            
             
Insugen R (recombinant human insulin biosimilar) / Biocon           
          
            
             
Insugen-N (isophane insulin biosimilar) / Biocon           
          
            
             
Kixelle (insulin aspart biosimilar) / Viatris, Biocon           
          
            
             
Nepexto (etanercept biosimilar) / Biocon, Lupin, YL Biologics, Nichi-Iko, Viatris